SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-030021
Filing Date
2021-03-01
Accepted
2021-03-01 16:30:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm218268d1_sc13ga.htm SC 13G/A 42187
  Complete submission text file 0001104659-21-030021.txt   43393
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Subject) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-57843 | Film No.: 21698313
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
ROTHBLATT MARTINE A (Filed by) CIK: 0001106578 (see all company filings)

Type: SC 13G/A